RNA
NASDAQ
$11.76
Atrium Therapeutics Inc (RNA)
Avidity Biosciences, Inc., a biopharmaceutical company, is dedicated to the development of oligonucleotide-based therapies. The company is headquartered in La Jolla, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $25 (+112.59%)
Market Cap
$210M
P/B Ratio
0.91
Beta (5Y)
0.82
Price Chart
Valuation
Market Cap$210M
P/S5.70
P/B0.91
Profitability
Gross Profit (TTM)-$12M
Profit Margin-84.7%
Operating Margin-88%
Growth & Risk
Beta (5Y)0.82
Sharpe Ratio-1.13